| |
| |
|
| Insider
Information: |
Tatsis Ourania |
| Relationship: |
EVP, Chief Reg. & Qual... |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
55,804 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$22,180,974 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
55,804 |
|
|
| Total
Value |
$22,180,974 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, Chief Reg. & Qual... |
2024-02-26 |
55,804 |
2019-10-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-26 |
4 |
AS |
$425.70 |
$150,698 |
D/D |
(354) |
55,804 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-23 |
4 |
D |
$431.79 |
$1,428,793 |
D/D |
(3,309) |
56,158 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-21 |
4 |
AS |
$421.77 |
$151,837 |
D/D |
(360) |
59,467 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-20 |
4 |
AS |
$420.79 |
$201,979 |
D/D |
(480) |
59,827 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-20 |
4 |
D |
$420.58 |
$1,418,616 |
D/D |
(3,373) |
60,307 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-16 |
4 |
D |
$424.01 |
$1,907,621 |
D/D |
(4,499) |
63,680 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-12 |
4 |
AS |
$420.24 |
$131,955 |
D/D |
(314) |
68,179 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-09 |
4 |
D |
$422.74 |
$887,754 |
D/D |
(2,100) |
68,493 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-07 |
4 |
A |
$0.00 |
$0 |
D/D |
7,114 |
70,593 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2024-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
14,842 |
63,479 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-08-23 |
4 |
AS |
$355.00 |
$887,500 |
D/D |
(2,500) |
48,637 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-08-10 |
4 |
AS |
$345.79 |
$1,988,293 |
D/D |
(5,750) |
51,137 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-27 |
4 |
AS |
$287.20 |
$101,768 |
D/D |
(354) |
56,805 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-24 |
4 |
D |
$289.12 |
$956,409 |
D/D |
(3,308) |
57,159 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-21 |
4 |
AS |
$291.01 |
$141,002 |
D/D |
(480) |
60,467 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-17 |
4 |
D |
$292.85 |
$1,317,239 |
D/D |
(4,498) |
60,947 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-14 |
4 |
AS |
$295.89 |
$95,527 |
D/D |
(320) |
65,445 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-13 |
4 |
D |
$298.26 |
$893,289 |
D/D |
(2,995) |
66,040 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-13 |
4 |
AS |
$295.84 |
$82,223 |
D/D |
(275) |
65,765 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-10 |
4 |
D |
$294.33 |
$405,292 |
D/D |
(1,377) |
69,035 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2023-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,322 |
70,412 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2022-08-09 |
4 |
AS |
$297.54 |
$418,557 |
D/D |
(1,400) |
46,090 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2022-03-17 |
4 |
AS |
$250.10 |
$708,572 |
D/D |
(2,833) |
47,356 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2022-02-25 |
4 |
AS |
$228.88 |
$75,058 |
D/D |
(325) |
50,189 |
0 |
% |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Reg. & Quality Off. |
• – – |
2022-02-24 |
4 |
D |
$227.86 |
$590,157 |
D/D |
(2,590) |
50,514 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
